Explore
Trendline
Novavax Shareholder Challenges CEO Pay Amid Declining Shareholder Value
Novavax Shareholder Challenges CEO Pay Amid Declining Shareholder Value
Read More
Trendline
Activist Investor Criticizes Novavax Over Vaccine Sales and Management
Activist Investor Criticizes Novavax Over Vaccine Sales and Management
Read More
Trendline
Activist Investor Criticizes Novavax Over Vaccine Sales and Management Strategy
Activist Investor Criticizes Novavax Over Vaccine Sales and Management Strategy
Read More
Trendline
Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions
Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions
Read More
Trendline
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee
Read More
Trendline
Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial
Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial
Read More
Trendline
Warren Buffett Continues Active Role at Berkshire Hathaway Post-CEO Retirement
Warren Buffett Continues Active Role at Berkshire Hathaway Post-CEO Retirement
Read More
Trendline
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Read More
Trendline
CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Growth
CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Growth
Read More
Trendline
Sanofi's Lunsekimig Shows Mixed Results in Clinical Trials for Respiratory and Skin Conditions
Sanofi's Lunsekimig Shows Mixed Results in Clinical Trials for Respiratory and Skin Conditions
Read More
Trendline
Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline
Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline
Read More
Trendline
Mark Cuban Highlights AI Dilemma for CEOs, Predicts Stock Challenges
Mark Cuban Highlights AI Dilemma for CEOs, Predicts Stock Challenges
Read More